In order to investigate the retrograde spread in the colon and its relationship to the extent of the diseased area, the authors evaluated a 100ml enema of mesalazine (5-aminosalicylic acid, ‘Pentasa’) 1g in a consecutive series of 30 patients with ulcerative colitis.
The enema was labelled with 10 MBq 99mtechnetium-human serum albumin microcolloid. Sequential scintigraphic imaging was performed in all patients, and the results compared with the extension of the disease as found by colonoscopy. If the enema reached the entire affected area it was interpreted as ‘topically adequate’.
In 80% of the patients there was retrograde spread of the enema beyond the rectosigmoid, thus reaching the affected area in ulcerative colitis. No relationship was found between the extent of dispersion of the enema and the time of defecation prior to scintigraphy.
The authors conclude that a 100ml ‘Pentasa’ enema may be adequate for treatment of ulcerative colitis extending up to the splenic flexure.
Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2: 892–895, 1977PubMedCrossRefGoogle Scholar
Campieri M, Lanfranchi GA, Bazzocchi G, Brignola C, Sarti F, et al. Treatment of ulcerative colitis with high dose 5-amino salicylic acid enemas. Lancet 2: 270–271, 1981PubMedCrossRefGoogle Scholar
Campieri M, Lanfranchi GA, Brignola G, Gionchetti P, Minguzz MR, et al. Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis. Diseases of the Colon and Rectum 29: 108–110, 1986PubMedCrossRefGoogle Scholar
Danish 5-ASA Group. Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. Digestive Diseases and Sciences 6: 598–602, 1987CrossRefGoogle Scholar
Farthing MJC, Rutland MD, Clark ML. Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis. British Medical Journal 2: 822–824, 1979PubMedCrossRefGoogle Scholar
Hardy JG, Lee SW, Clark AG, Reynolds JR. Enema volume and spreading. International Journal of Pharmaceutics 31: 151–155, 1983CrossRefGoogle Scholar
Hay DJ. Spreading characteristics of proprietary rectal steroid preparations. In Wilson et al. (Eds) Radionuclide imaging in drug research, Croom Helm, London, 1982Google Scholar
Hay DJ, Sharma H, Irving MH. Spread of steroid-containing foam after intrarectal administration. British Medical Journal 2: 1751–1753, 1979CrossRefGoogle Scholar
Mulder CJJ, Tytgat GNJ, Wiltink EHH, Houthoff H-J. Comparison of 5-aminosalicylic acid (3g) and prednisolone phosphate sodium enemas (30mg) in the treatment of distal ulcerative colitis. Scandinavian Journal of Gastroenterology 23: 1005–1008, 1988PubMedCrossRefGoogle Scholar
Swarbrick ET, Loose H, Lennard-Jones JE. Enema volumes an important factor in successful topical corticosteroid treatment of colitis. Proceedings of the Royal Society of Medicine 67: 753–754, 1974PubMedGoogle Scholar
van Buul MMC, Mulder CJJ, Wiltink EHH, van Royen EA, Tytgat GNJ. Retrograde spread of therapeutic enemas in patients with inflammatory bowel disease. Hepato-Gastroenterology 36: 199–201, 1989PubMedGoogle Scholar
van Hees PAM, Bakker JH, van Tongeren JHM. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis; a study to determine the active therapeutic moiety of sulphasalazine. Gut 21: 632–635, 1980PubMedCrossRefGoogle Scholar